Evodiamine, on the other hand, inhibits adipocyte differentiation by blocking the ERK/MAPK pathway and modulates the NF-κB signaling pathway to reduce inflammatory responses [22,23,47], demonstrating significant anti-obesity effects. This evidence concerns the gene NFKB1 and obesity disorder.